{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:12:52Z","timestamp":1792127572692,"version":"4.4.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1067\/mai.2000.111238","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:20:13Z","timestamp":1027570813000},"page":"1019-1032","source":"Crossref","is-referenced-by-count":214,"title":["Allergic and immunologic disorders of the eye. Part II: Ocular allergy"],"prefix":"10.1067","volume":"106","author":[{"given":"Leonard","family":"Bielory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2000.111238_bib1","doi-asserted-by":"crossref","first-page":"S808","DOI":"10.1016\/S0091-6749(97)80040-1","article-title":"Prevalence of allergic rhinitis in the United States","volume":"99","author":"Nathan","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1081-1206(10)63152-3","article-title":"Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.111238_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(94)90349-2","article-title":"Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials","volume":"93","author":"Juniper","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0091-6749(99)70463-X","article-title":"Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses","volume":"103","author":"Ray","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib5","first-page":"5","article-title":"Current concepts in ocular allergy","volume":"67","author":"Friedlaender","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2000.111238_bib6","first-page":"151","article-title":"The role of ocular manifestations in childhood allergy syndromes","volume":"18","author":"Marrache","year":"1978","journal-title":"Rev Fr Allergol Immunol Clin"},{"key":"10.1067\/mai.2000.111238_bib7","first-page":"1","article-title":"Epidemiology of hay fever and perennial allergic rhinitis","volume":"21","author":"Weeks","year":"1987","journal-title":"Monogr Allergy"},{"key":"10.1067\/mai.2000.111238_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2222.1998.0280s6008.x","article-title":"Why is allergy increasing?\u2014environmental factors","volume":"28","author":"Davies","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2000.111238_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1081-1206(10)62612-9","article-title":"National guidelines needed to manage rhinitis and prevent complications","volume":"82","author":"Rachelefsky","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.111238_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1542\/pir.20-4-110","article-title":"Allergy: etiology and epidemiology","volume":"20","author":"Nimmagadda","year":"1999","journal-title":"Pediatr Rev"},{"key":"10.1067\/mai.2000.111238_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2222.2000.00793.x","article-title":"Ethnicity, childhood environment and atopic disorder","volume":"30","author":"Hjern","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2000.111238_bib12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0091-6749(93)90327-C","article-title":"Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis","volume":"91","author":"Ciprandi","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib13","first-page":"513","article-title":"Perennial allergic conjunctivitis: definition, clinical characteristics and prevalence. A comparison with seasonal allergic conjunctivitis","volume":"105","author":"Dart","year":"1986","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1067\/mai.2000.111238_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0091-6749(98)70088-0","article-title":"Allergic responses to pollen of ornamental plants: high incidence in the general atopic population and especially among flower growers","volume":"102","author":"Goldberg","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib15","first-page":"209","article-title":"Value of lacrimal IgE determination and conjunctival cytology in the diagnosis of chronic conjunctivitis","volume":"21","author":"Bourcier","year":"1998","journal-title":"J Fr Ophtalmol"},{"key":"10.1067\/mai.2000.111238_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/02713688809031795","article-title":"Late-phase reaction in topically induced ocular anaphylaxis in the rat","volume":"7","author":"Trocme","year":"1988","journal-title":"Curr Eye Res"},{"key":"10.1067\/mai.2000.111238_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0091-6749(88)90020-6","article-title":"Inflammatory changes in the conjunctival scrapings after allergen provocation in humans","volume":"82","author":"Bonini","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0091-6749(05)80148-4","article-title":"Allergen dose response and late symptoms in a human model of ocular allergy","volume":"86","author":"Bonini","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000267025","article-title":"Histology of ocular late-phase reaction in guinea pigs passively sensitized with IgG1 antibody","volume":"22","author":"Leonardi","year":"1990","journal-title":"Ophthalmic Res"},{"key":"10.1067\/mai.2000.111238_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000267007","article-title":"Clinical patterns of ocular anaphylaxis in guinea pigs passively sensitized with IgG1 antibody","volume":"22","author":"Leonardi","year":"1990","journal-title":"Ophthalmic Res"},{"key":"10.1067\/mai.2000.111238_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/09273949309057059","article-title":"Passive transfer of the ocular late phase reaction","volume":"1","author":"Bonini","year":"1993","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1067\/mai.2000.111238_bib22","first-page":"63","article-title":"Platelet activating factor induced inflammation following topical ocular challenge","volume":"31","author":"George","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0091-6749(93)90327-C","article-title":"Ocular challenge and hyper-responsiveness to histamine in patients with allergic conjunctivitis","volume":"91","author":"Ciprandi","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0091-6749(00)90080-0","article-title":"The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis","volume":"105","author":"Magone","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0091-6749(88)90969-4","article-title":"Effect of levocabastine, a new H1 antagonist, in a conjunctival provocation test with allergens","volume":"82","author":"Zubler","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0161-6420(91)32322-4","article-title":"Clinical features of atopic keratoconjunctivitis","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib27","first-page":"21","article-title":"Ocular complications of atopic dermatitis","volume":"19","author":"Garrity","year":"1984","journal-title":"Can J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib28","first-page":"381","article-title":"Ophthalmological changes in atopic dermatitis","volume":"45","author":"Karel","year":"1965","journal-title":"Acta Dermatol Venerol"},{"key":"10.1067\/mai.2000.111238_bib29","first-page":"479","article-title":"Klinische verlaufsbeobachtungen bei neurodermatitis atopic dem kleinkindersalter, Eine katamnestische untersuchung anhand von 121 fallen","volume":"60","author":"Schudel","year":"1985","journal-title":"Z Hautkr"},{"key":"10.1067\/mai.2000.111238_bib30","first-page":"889","article-title":"Atopic dermatitis and its ophthalmic complications","volume":"53","author":"Oshinskie","year":"1982","journal-title":"J Am Optom Assoc"},{"key":"10.1067\/mai.2000.111238_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004397-198502510-00005","article-title":"Ocular complications of atopic dermatitis and other eczemas","volume":"25","author":"Rich","year":"1985","journal-title":"Int Ophthalmol Clin"},{"key":"10.1067\/mai.2000.111238_bib32","first-page":"267","article-title":"Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study","volume":"95","author":"Easty","year":"1975","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1067\/mai.2000.111238_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0021-5155(98)00061-6","article-title":"Ocular surface disease in atopic dermatitis","volume":"43","author":"Dogru","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib34","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(90)32477-6","article-title":"Atopic keratoconjunctivitis","volume":"97","author":"Foster","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archopht.1940.00870010043004","article-title":"Atopic cataracts","volume":"24","author":"Beetham","year":"1940","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib36","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/bmj.2.5468.977","article-title":"Eczema and keratoconus","volume":"2","author":"Copeman","year":"1965","journal-title":"BMJ"},{"key":"10.1067\/mai.2000.111238_bib37","first-page":"97","article-title":"Keratoconus changes in corneal topography and allergy. Study of 3 groups of patients","volume":"20","author":"Jacq","year":"1997","journal-title":"J Fr Ophtalmol"},{"key":"10.1067\/mai.2000.111238_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archderm.1955.03730330017003","article-title":"Occurrence of cataracts and keratoconus with atopic dermatitis","volume":"72","author":"Brunsting","year":"1955","journal-title":"Arch Dermatol"},{"key":"10.1067\/mai.2000.111238_bib39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1755-3768.1959.tb03462.x","article-title":"Ocular changes in 100 cases of Besnier\u2019s prurigo (atopic dermatitis)","volume":"37","author":"Kornerup","year":"1959","journal-title":"Acta Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000249527","article-title":"Atopic cataracts in a Japanese population. With special reference to factors possibly relevant to cataract formation","volume":"170","author":"Uehara","year":"1985","journal-title":"Dermatologica"},{"key":"10.1067\/mai.2000.111238_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000308965","article-title":"Ocular findings in atopic dermatitis with special reference to the clinical features of the atopic cataract","volume":"180","author":"Amemiya","year":"1980","journal-title":"Ophthalmologica"},{"key":"10.1067\/mai.2000.111238_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bjo.82.1.82","article-title":"Systemic and local immunological features of atopic dermatitis patients with ocular complications","volume":"82","author":"Uchio","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib43","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bjo.80.6.556","article-title":"Eosinophil cationic protein in tears in allergic conjunctivitis","volume":"80","author":"Montab","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib44","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0002-9394(53)92176-X","article-title":"Atopic keratoconjunctivitis","volume":"36","author":"Hogan","year":"1953","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib45","first-page":"389","article-title":"Cataracts occur in patients with atopic dermatitis when the serum IgE increases","volume":"101","author":"Sasabe","year":"1997","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1067\/mai.2000.111238_bib46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1346-8138.1999.tb02068.x","article-title":"Cataract and retinal detachment in patients with severe atopic dermatitis who were withdrawn from the use of topical corticosteroid","volume":"26","author":"Taniguchi","year":"1999","journal-title":"J Dermatol"},{"key":"10.1067\/mai.2000.111238_bib47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archopht.1952.00920010033004","article-title":"Retinal detachments occurring in cataract associated with neurodermatitis","volume":"48","author":"Coles","year":"1952","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib48","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archopht.1954.00920050858006","article-title":"Cataract and retinal detachment associated with atopic dermatitis","volume":"52","author":"Hurlbut","year":"1954","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib49","first-page":"96","article-title":"Retinal detachment associated with atopic dermatitis and cataracts","volume":"49","author":"Ingram","year":"1965","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0161-6420(92)31995-5","article-title":"Role of Staphylococcus aureus in chronic allergic conjunctivitis","volume":"99","author":"Tuft","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib51","first-page":"265","article-title":"Atopic keratoconjunctivitis","volume":"50","author":"Hogan","year":"1952","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1067\/mai.2000.111238_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1006\/exer.1997.0398","article-title":"Further studies on the immunopathology of atopic keratoconjunctivitis using flow cytometry","volume":"65","author":"Avunduk","year":"1997","journal-title":"Exp Eye Res"},{"key":"10.1067\/mai.2000.111238_bib53","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-6749(97)70279-3","article-title":"T-cell cytokines in chronic allergic disease","volume":"100","author":"Metz","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2222.2000.00699.x","article-title":"Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis","volume":"30","author":"Uchio","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2000.111238_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/bjo.81.5.402","article-title":"Increased number of IgE positive Langerhans cells in the conjunctiva of patients with atopic dermatitis","volume":"81","author":"Yoshida","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0923-1811(98)00056-5","article-title":"Reduced amount of secretory component of IgA secretion in tears of patients with atopic dermatitis","volume":"19","author":"Toshitani","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1067\/mai.2000.111238_bib57","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/bjo.82.7.797","article-title":"Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis","volume":"82","author":"Yokoi","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib58","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0161-6420(91)32154-7","article-title":"Immunopathology of atopic keratoconjunctivitis","volume":"98","author":"Foster","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1034\/j.1600-0420.1999.770516.x","article-title":"Vernal keratoconjunctivitis in a Stockholm ophthalmic centre\u2014epidemiological, functional, and immunologic investigations","volume":"77","author":"Montan","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1067\/mai.2000.111238_bib60","first-page":"88","article-title":"Ocular complications of vernal keratoconjunctivitis","volume":"34","author":"Tabbara","year":"1999","journal-title":"Can J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0091-6749(05)80120-4","article-title":"Human conjunctival mast cells: distribution of MCT and MCTc in vernal conjunctivitis and giant papillary conjunctivitis","volume":"86","author":"Irani","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000235344","article-title":"Increased numbers of TH2 like CD4+ T cells in target organs and in the allergen specific repertoire of allergic patients","volume":"94","author":"Romagnani","year":"1991","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1067\/mai.2000.111238_bib63","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.4049\/jimmunol.146.4.1169","article-title":"Accumulation of TH-2 like helper T cells in the conjunctiva of patients with vernal conjunctivitis","volume":"146","author":"Maggi","year":"1991","journal-title":"J Immunol"},{"key":"10.1067\/mai.2000.111238_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1398-9995.1999.00738.x","article-title":"Serum levels of soluble intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and interleukin-2 receptor in patients with vernal keratoconjunctivitis and allergic conjunctivitis","volume":"54","author":"Uchio","year":"1999","journal-title":"Allergy"},{"key":"10.1067\/mai.2000.111238_bib65","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0161-6420(80)35158-0","article-title":"Tear histamine levels in vernal conjunctivitis and other ocular inflammations","volume":"87","author":"Abelson","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/09273949509057807","article-title":"The role of eosinophil cationic protein (ECP) and histamine in vernal keratoconjunctivitis","volume":"3","author":"Secchi","year":"1995","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1067\/mai.2000.111238_bib67","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1398-9995.1995.tb01209.x","article-title":"Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis","volume":"50","author":"Leonardi","year":"1995","journal-title":"Allergy"},{"key":"10.1067\/mai.2000.111238_bib68","first-page":"682","article-title":"Deposition of eosinophil cationic protein in conjunctival tissues and tears in vernal keratoconjunctivitis","volume":"32","author":"Saiga","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib69","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bjo.80.6.556","article-title":"Eosinophil cationic protein in tears in allergic conjunctivitis","volume":"80","author":"Montab","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib70","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0002-9394(14)75637-5","article-title":"Eosinophil granule major basic protein and Charcot-Leyden crystal protein in human tears","volume":"92","author":"Udell","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib71","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/eye.1998.67","article-title":"Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis","volume":"12","author":"Akman","year":"1998","journal-title":"Eye"},{"key":"10.1067\/mai.2000.111238_bib72","first-page":"1272","article-title":"Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases","volume":"39","author":"Lambiase","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9394(14)73261-1","article-title":"Conjunctival deposition of eosinophil granule major basic protein in vernal conjunctivitis and contact lens-associated conjunctivitis","volume":"108","author":"Trocm\u00e9","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib74","first-page":"1161","article-title":"Eosinophil granule major basic protein inhibits corneal epithelial wound healing in vitro","volume":"32","author":"Trocm\u00e9","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib75","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0002-9394(14)71463-1","article-title":"Eosinophil major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis","volume":"115","author":"Trocm\u00e9","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib76","first-page":"35","article-title":"Toxic effects of eosinophil cationic protein on cultured human corneal epithelium","author":"Hallberg","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib77","first-page":"3051","article-title":"Eosinophil granule major basic protein inhibition of corneal epithelial wound healing","volume":"35","author":"Trocm\u00e9","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib78","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000024310","article-title":"IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells","volume":"12","author":"Fukagawa","year":"2000","journal-title":"Arch Allergy Immunol"},{"key":"10.1067\/mai.2000.111238_bib79","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9394(99)00295-0","article-title":"Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases","volume":"129","author":"Leonardi","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bjo.81.1.23","article-title":"Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis","volume":"81","author":"Leonardi","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00004397-199103120-00015","article-title":"The contact lens patient and the ocular allergies","volume":"31","author":"Donshik","year":"1991","journal-title":"Int Ophthalmol Clin"},{"key":"10.1067\/mai.2000.111238_bib82","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archopht.1979.01020010450011","article-title":"Giant papillary conjunctivitis with ocular prostheses","volume":"97","author":"Srinivasan","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib83","first-page":"368","article-title":"Giant papillary conjunctivitis after keratoplasty","volume":"92","author":"Sugar","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib84","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/archopht.1987.01060050037027","article-title":"Giant papillary conjunctivitis associated with extruded scleral buckle","volume":"105","author":"Robin","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib85","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0002-9394(87)90249-2","article-title":"Giant papillary conjunctivitis associated with cyanoacrylate glue","volume":"104","author":"Carlson","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00003226-199301000-00014","article-title":"Unusual causes of giant papillary conjunctivitis","volume":"12","author":"Heidemann","year":"1993","journal-title":"Cornea"},{"key":"10.1067\/mai.2000.111238_bib87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00003226-199010000-00017","article-title":"Giant papillary conjunctivitis associated with elevated corneal deposits","volume":"9","author":"Dunn","year":"1990","journal-title":"Cornea"},{"key":"10.1067\/mai.2000.111238_bib88","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/02713688809047033","article-title":"Immunocytochemical analysis of contact lens surface deposits in transmission electron microscopy","volume":"7","author":"Versura","year":"1988","journal-title":"Curr Eye Res"},{"key":"10.1067\/mai.2000.111238_bib89","first-page":"121","article-title":"Analysis of glycoprotein deposits on disposable contact lenses","volume":"33","author":"Tripathi","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib90","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archopht.1979.01020010223006","article-title":"Russell bodies in contact-lens-associated giant papillary conjunctivitis","volume":"97","author":"Henriquez","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib91","first-page":"208","article-title":"Neutrophil chemotactic factors in tears of giant papillary conjunctivitis patients","volume":"32","author":"Elgebaly","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib92","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004397-198802840-00010","article-title":"Giant papillary conjunctivitis","volume":"28","author":"Allansmith","year":"1988","journal-title":"Int Ophthalmol Clin"},{"key":"10.1067\/mai.2000.111238_bib93","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/09273949509085038","article-title":"Effect of extended wear disposable contact lenses on tear LTC4 in giant papillary conjunctivitis","volume":"3","author":"Irke\u00e7","year":"1995","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1067\/mai.2000.111238_bib94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1076\/ocii.7.1.35.8107","article-title":"Role of tear inflammatory mediators in contact lens-associated giant papillary conjunctivitis in soft contact lens wearers","volume":"7","author":"Irkec","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1067\/mai.2000.111238_bib95","first-page":"215","article-title":"Lid, conjunctival, and corneal complications of contact lenses","author":"Stenson","year":"1987"},{"key":"10.1067\/mai.2000.111238_bib96","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0039-6257(89)90128-8","article-title":"Disposable soft contact lenses","volume":"34","author":"Driebe","year":"1989","journal-title":"Surv Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib97","first-page":"1371","article-title":"R\u00e9\u00e9quipement avec les lentilles jetables de patients porteurs de conjonctivite papillaire g\u00e9ante. Premiers r\u00e9sultats","volume":"89","author":"Coursaux","year":"1989","journal-title":"Bull Soc Ophthalmol Fr"},{"key":"10.1067\/mai.2000.111238_bib98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1081-1206(10)63510-7","article-title":"Impact on quality of life during an allergen challenge research trial","volume":"83","author":"Ellis","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.111238_bib99","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1990.01070060068051","article-title":"The effects of Vasocon-A in the allergen challenge model of acute conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0091-6749(94)90081-7","article-title":"Conjunctivitis medicamentosa","volume":"94","author":"Spector","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib101","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archopht.1981.03930010304018","article-title":"H2 receptors in the human ocular surface","volume":"99","author":"Abelson","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib102","first-page":"32","article-title":"H1 receptors in the human ocular surface [abstract]","volume":"20","author":"Weston","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ddr.430080115","article-title":"Drug receptor dissociation time, new tool for drug research: receptor binding affinity and drug receptor dissociation profiles of serotonin S2, dopamine D2, histamine H1 antagonists and opiates","volume":"8","author":"Leysen","year":"1986","journal-title":"Drug Develop Res"},{"key":"10.1067\/mai.2000.111238_bib104","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1398-9995.1990.tb00531.x","article-title":"Absence of central effects with levocabastine eyedrops","volume":"45","author":"Arriaga","year":"1990","journal-title":"Allergy"},{"key":"10.1067\/mai.2000.111238_bib105","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2222.1991.tb03197.x","article-title":"Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis","volume":"21","author":"Azevedo","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2000.111238_bib106","first-page":"502","article-title":"The effects of levocabastine, a new highly potent and specific histamine H1 receptor antagonist, in the ocular allergen challenge model of allergic conjunctivitis [abstract]","volume":"30","author":"Smith","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib107","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1398-9995.1985.tb00255.x","article-title":"A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis","volume":"40","author":"Pipkorn","year":"1985","journal-title":"Allergy"},{"key":"10.1067\/mai.2000.111238_bib108","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000234274","article-title":"Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test","volume":"82","author":"Pecoud","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1067\/mai.2000.111238_bib109","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2165\/00003495-198938050-00005","article-title":"Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential","volume":"38","author":"McTavish","year":"1989","journal-title":"Drugs"},{"key":"10.1067\/mai.2000.111238_bib110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003495-199856010-00011","article-title":"Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1067\/mai.2000.111238_bib111","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0091-6749(93)90198-O","article-title":"Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge","volume":"91","author":"Ciprandi","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/S0161-6420(00)00349-3","article-title":"Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model","author":"Friedlaender","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib113","first-page":"S135","article-title":"Emedastine: pharmacological profile of a novel antihistamine for use in allergic conjunctivitis [abstract]","volume":"36","author":"Sharif","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib114","first-page":"116","article-title":"Clinical trials of topical disodium cromoglycate in vernal keratoconjunctivitis","volume":"12","author":"Hyams","year":"1975","journal-title":"J Pediatr Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1084\/jem.180.2.663","article-title":"Disodium cromoglycate inhibits S mu to the S epsilon deletional switch recombination and IgE synthesis in human B cells","volume":"180","author":"Loh","year":"1994","journal-title":"J Exp Med"},{"key":"10.1067\/mai.2000.111238_bib116","first-page":"395","article-title":"Sodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cells in vitro","volume":"84","author":"Kimata","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mai.2000.111238_bib117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00003495-198631020-00003","article-title":"Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease","volume":"31","author":"Sorkin","year":"1986","journal-title":"Drugs"},{"key":"10.1067\/mai.2000.111238_bib118","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000232051","article-title":"Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,385E: I. Activity in rats","volume":"56","author":"Johnson","year":"1978","journal-title":"Int Arch Appl Allergy Immunol"},{"key":"10.1067\/mai.2000.111238_bib119","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0161-6420(97)30223-1","article-title":"Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis","volume":"104","author":"Bonini","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib120","series-title":"A multicenter study in patients with allergic eye disorders","article-title":"A double-masked efficacy and safety evaluation of lodoxamide 0.1% ophthalmic solution versus opticrom 2%","author":"Verstappen","year":"1988"},{"key":"10.1067\/mai.2000.111238_bib121","first-page":"163","article-title":"Evaluation de l\u2019efficacite therapeutique d\u2019un collyre anti-allergique par test photographique","volume":"30","author":"Bloch-Michel","year":"1990","journal-title":"Rev Fr Allergol"},{"key":"10.1067\/mai.2000.111238_bib122","first-page":"573","article-title":"L\u2019acide N-acetyl aspartyl glutamique en collyre dans les conjunctivites de type allergique. Etude clinique comparative en double ensu","volume":"8","author":"Bonnet","year":"1985","journal-title":"J Fr Ophtalmol"},{"key":"10.1067\/mai.2000.111238_bib123","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-2008-1050733","article-title":"Klinische erptobung von N-acetyl-aspartyl-glutaminasaure augetropfen bei subakuter und chronischer atophischer konjunctivitis","volume":"188","author":"Van Bijsterveld","year":"1988","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1067\/mai.2000.111238_bib124","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/bjo.82.10.1135","article-title":"Treatment of common ocular allergic disorders: a comparison of lodoxamide and NAAGA","volume":"82","author":"Denis","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib125","first-page":"1252","article-title":"Characterization of the ocular antiallergic and antihistaminic effects of olopatadine, a novel drug for treating ocular allergic disease","volume":"278","author":"Sharif","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1067\/mai.2000.111238_bib126","first-page":"S1027","article-title":"Olopatadine (AL-4943A): pharmacological profile of a novel antihistamine\/antiallergic drug for use in allergic conjunctivitis [abstract]","volume":"37","author":"Sharif","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib127","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/eye.1998.67","article-title":"Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis","volume":"12","author":"Akman","year":"1998","journal-title":"Eye"},{"key":"10.1067\/mai.2000.111238_bib128","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archopht.117.5.643","article-title":"Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs","volume":"117","author":"Yanni","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib129","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9394(98)00044-0","article-title":"Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity","volume":"125","author":"Abelson","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1081-1206(10)62814-1","article-title":"Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model","volume":"81","author":"Abelson","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.111238_bib131","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1081-1206(10)63063-3","article-title":"Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells","volume":"79","author":"Yanni","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.111238_bib132","first-page":"313","article-title":"Inhibition of chemical mediator release from human leukocytes by a new antiasthma drug HC 20-511 (ketotifen)","volume":"14","author":"Tomioka","year":"1979","journal-title":"Mongr Allergy"},{"key":"10.1067\/mai.2000.111238_bib133","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2165\/00003495-198734050-00004","article-title":"Nedocromil sodium: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airway disease","volume":"34","author":"Gonzalez","year":"1987","journal-title":"Drugs"},{"key":"10.1067\/mai.2000.111238_bib134","first-page":"229","article-title":"Double blind comparative trial of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis [abstract]","volume":"29","author":"Stockwell","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib135","first-page":"57","article-title":"Evaluation of nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis","volume":"73","author":"Melamed","year":"1994","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.111238_bib136","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0091-6749(88)90257-6","article-title":"Efficacy of nedocromil sodium 2% ophthalmic solution in the treatment of ragweed seasonal allergic conjunctivitis [abstract]","volume":"81","author":"Hirsch","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib137","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0091-6749(88)90258-8","article-title":"Nedocromil sodium 2% ophthalmic solution in the treatment of ragweed seasonal allergic conjunctivitis [abstract]","volume":"81","author":"Jarmoszuk","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib138","first-page":"398","article-title":"A double bind group comparative study of 2% nedocromil sodium eye drops in the treatment of seasonal allergic conjunctivitis","volume":"64","author":"Leino","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2000.111238_bib139","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0002-9394(14)75754-X","article-title":"A multicenter double-blind group comparative study of the efficacy and safety of b.i.d, nedocromil sodium 2% ophthalmic solution in the treatment of allergic conjunctivitis","volume":"113","author":"Blumenthal","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/09273949309086532","article-title":"Studies comparing efficacy of nedocromil sodium eye drops with sodium cromoglycate and placebo in seasonal allergic conjunctivitis","volume":"1","author":"Leino","year":"1993","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1067\/mai.2000.111238_bib141","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/09273949409057074","article-title":"Nedocromil sodium treats symptoms of perennial allergic conjunctivitis not fully controlled by sodium cromoglycate","volume":"2","author":"van Bijsterveld","year":"1994","journal-title":"Ocul Immunol Inflamm"},{"issue":"Suppl 6","key":"10.1067\/mai.2000.111238_bib142","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2222.1998.0280s6044.x","article-title":"Treating severe eye allergy","volume":"23","author":"Verin","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2000.111238_bib143","first-page":"360","article-title":"Mechanisms of action of ketorolac (AcularTM) in alleviating allergic conjunctival itching [abstract]","volume":"95","author":"Woodward","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib144","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0039-6257(93)90037-8","article-title":"Double-masked, paired comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eye drops in the treatment of seasonal allergic conjunctivitis","volume":"38","author":"Tinkelman","year":"1993","journal-title":"Surv Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0039-6257(93)90038-9","article-title":"Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis","volume":"38","author":"Ballas","year":"1993","journal-title":"Surv Ophthalmol"},{"issue":"487","key":"10.1067\/mai.2000.111238_bib146","first-page":"2394","article-title":"Evaluation of flurbiprofen in the treatment of antigen-induced allergic conjunctivitis [abstract]","volume":"31","author":"Bishop","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib147","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.1998.14.137","article-title":"A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis","volume":"14","author":"Tauber","year":"1998","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1067\/mai.2000.111238_bib148","first-page":"178","article-title":"Loteprednol etabonate: a review of ophthalmic clinical studies","volume":"55","author":"Howes","year":"2000","journal-title":"Pharmazie"},{"key":"10.1067\/mai.2000.111238_bib149","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(14)71128-6","article-title":"A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group","volume":"123","author":"Dell","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9394(14)70171-0","article-title":"A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group I","volume":"123","author":"Friedlaender","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib151","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"1","author":"Noon","year":"1911","journal-title":"Lancet"},{"key":"10.1067\/mai.2000.111238_bib152","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1398-9995.1986.tb00289.x","article-title":"A double blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarium preparation. I. Clinical results","volume":"41","author":"Dreborg","year":"1986","journal-title":"Allergy"},{"key":"10.1067\/mai.2000.111238_bib153","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0091-6749(94)70067-2","article-title":"Monoclonal antibody-standardized cat extract immunotherapy: risk benefit effects from double blind placebo study","volume":"93","author":"Alvarez-Cuesta","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib154","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1081-1206(10)63483-7","article-title":"Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure","volume":"77","author":"Donovan","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.111238_bib155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0385-8146(96)00028-4","article-title":"Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination","volume":"24","author":"Ito","year":"1997","journal-title":"Auris Nasus Larynx"},{"key":"10.1067\/mai.2000.111238_bib156","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib157","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9394(86)90819-6","article-title":"Cyclosporine eye drops for the treatment of severe vernal keratoconjunctivitis","volume":"101","author":"BenEzra","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib158","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","article-title":"Topical cyclosporine in vernal keratoconjunctivitis","volume":"98","author":"Bleik","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib159","first-page":"2686","article-title":"Topical cyclosporine inhibits mast cell mediated conjunctivitis","volume":"37","author":"Whitcup","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib160","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/1523-1747.ep12499960","article-title":"Anti-inflammatory effect of cyclosporin A on human skin mast cells","volume":"98","author":"Stellato","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mai.2000.111238_bib161","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.154.3.1391","article-title":"Dexamethasone or cyclosporine A suppress mast cell\u2013leukocyte cytokine cascade","volume":"154","author":"Wershil","year":"1995","journal-title":"J Immunol"},{"key":"10.1067\/mai.2000.111238_bib162","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0161-6420(97)30144-4","article-title":"Systemic cyclosporine A in severe atopic keratoconjunctivitis","volume":"104","author":"Hoang-Xuan","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib163","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sail","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1067\/mai.2000.111238_bib164","first-page":"11","article-title":"Physicochemical proterie of FK 506, a novel immunosuppressant isolated from Streptomyces tsukubaensis","volume":"19","author":"Tanaka","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1067\/mai.2000.111238_bib165","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.146.7.2374","article-title":"FK-506, a potent novel inhibitor release of proinflammatory mediators from human Fc epsilon RI+ cells","volume":"146","author":"De Paulis","year":"1991","journal-title":"J Immunol"},{"key":"10.1067\/mai.2000.111238_bib166","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol Today"},{"key":"10.1067\/mai.2000.111238_bib167","first-page":"2737","article-title":"Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye","volume":"34","author":"Pleyer","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib168","first-page":"834","article-title":"The immunosuppressive effects of 0.025% cyclosporine eye drops in alpha cyclodextrin on rabbit corneal allografts","volume":"96","author":"Takano","year":"1992","journal-title":"Acta Societatis Ophthalmologica Japonicae"},{"key":"10.1067\/mai.2000.111238_bib169","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.144.5.1689","article-title":"Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction with S-antigen","volume":"144","author":"Nussenblatt","year":"1990","journal-title":"J Immunol"},{"key":"10.1067\/mai.2000.111238_bib170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/08916939209148457","article-title":"Inhibition of experimental autoimmune uveitis by oral administration of S-antigen and synthetic peptides","volume":"12","author":"Vrabec","year":"1992","journal-title":"Autoimmunity"},{"key":"10.1067\/mai.2000.111238_bib171","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/bjo.77.3.171","article-title":"Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis: a preliminary report of intranasal induction of tolerance with retinal antigens","volume":"77","author":"Dick","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1067\/mai.2000.111238_bib172","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/09273949409057799","article-title":"Conjunctival instillation of retinal antigens induced tolerance","volume":"2","author":"Dua","year":"1994","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1067\/mai.2000.111238_bib173","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09273949509085039","article-title":"Suppression of experimental allergic conjunctivitis in guinea pigs by oral administration of antigen","volume":"3","author":"Koizumi","year":"1995","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1067\/mai.2000.111238_bib174","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1034\/j.1398-9995.1999.00077.x","article-title":"Sublingualoswallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis","volume":"54","author":"Pradalier","year":"1999","journal-title":"Allergy"},{"key":"10.1067\/mai.2000.111238_bib175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/clim.1999.4775","article-title":"Blocking ICAM-1 (CD54) and LFA-1 (CD1 la) inhibits experimental allergic conjunctivitis","volume":"93","author":"Whitcup","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1067\/mai.2000.111238_bib176","first-page":"3041","article-title":"Prevention of allergic eye disease by treatment with IL-1 receptor antagonist","volume":"40","author":"Keane-Myers","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib177","first-page":"1336","article-title":"Soluble P-selectin glycoprotein ligand 1 inhibits ocular inflammation in a murine model of allergy","volume":"40","author":"Strauss","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib178","first-page":"45","article-title":"Double-blind comparison of HEPP (IgE pentapeptide) 0.5% ophthalmic solution and sodium cromolyn ophthalmic solution, USP 4%, in patients having allergic conjunctivitis [abstract]","volume":"29","author":"Floyd","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mai.2000.111238_bib179","first-page":"83","article-title":"Safety and efficacy of human IgE pentapeptide","volume":"52","author":"Cohen","year":"1985","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2000.111238_bib180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0091-6749(97)70202-1","article-title":"Use of an anti-IgE humanized antibody in ragweed induced allergic rhinitis","volume":"100","author":"Casale","year":"1997","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674900754005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674900754005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:16:19Z","timestamp":1680534979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674900754005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":180,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0091674900754005"],"URL":"https:\/\/doi.org\/10.1067\/mai.2000.111238","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}